Visepegenatide
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects
PegBio Co · Phase 1/2 · Completed · Enrollment 32
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| PB-119 | Obesity or overweight | n/r | 1 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 1 | n/r | n/r |